| Upcoming events on FATE THERAPEUTICS, INC. |
|
| 03/08/21 | | FY 2020 Earnings Release (Projected) |
| 05/13/21 | | Q1 2021 Earnings Release (Projected) |
| 08/11/21 | | Interim 2021 Earnings Release (Projected) |
| 11/09/21 | | Q3 2021 Earnings Release (Projected) |
|
| Past events on FATE THERAPEUTICS, INC. |
|
| 12/05/20 | | American Society of Hematology Meeting |
| 12/04/20 | 09:30pm | | Business Update Call |
| 12/01/20 | 08:30pm | | Evercore ISI HealthCONx Conference |
| 11/19/20 | 02:05pm | | Jefferies Healthcare Conference |
|
| Upcoming sector events for FATE THERAPEUTICS, INC. |
|
|
| |
|
| Past sector events for FATE THERAPEUTICS, INC. |
|
|
|
|
|
| Annual results | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 (e) |
Sales
M $ |
Released
Forecast
Spread | 2,43
2,03
20% | 4,40
4,35
1,1% | 4,11
4,02
2,2% | 4,74
4,08
16% | 10,7
9,62
11% |
20,6
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | -27,8
-28,2
1,4% | -32,0
-33,1
3,5% | -42,1
-40,8
-3,3% | -67,1
-65,9
-1,7% | -101
-99,9
-0,82% |
-130
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | -30,0
-30,3
1,2% | -33,5
-34,9
4,1% | -43,0
-41,5
-3,4% | -66,6
-65,6
-1,5% | -98,1
-97,4
-0,72% |
-145
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | -30,0
-30,3
1,2% | -33,5
-35,0
4,3% | -43,0
-41,6
-3,3% | -66,6
-66,0
-0,98% | -98,1
-97,8
-0,40% |
-146
|
Net income
$ |
Released
Forecast
Spread | -1,18
-1,19
0,51% | -1,05
-1,14
7,5% | -1,02
-0,97
-5,2% | -1,19
-1,18
-0,73% | -1,44
-1,44
0,21% |
-1,81
| | Announcement Date | 03/03/2016 | 03/16/2017 | 03/05/2018 | 03/05/2019 | 03/02/2020 | |
|
|
|
| Quarterly results | 2018 Q2 | 2018 Q3 | 2018 Q4 | 2019 Q1 | 2019 Q2 | 2019 Q3 | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 (e) | 2021 Q1 (e) | 2021 Q2 (e) | 2021 Q3 (e) | 2021 Q4 (e) |
Sales
M $ |
Released
Forecast
Spread | 1,03
1,02
1,0% | 1,03
1,24
-17% | 1,66
1,02
63% | 2,63
2,01
31% | 2,82
1,09
159% | 2,43
1,75
38% | 2,80
1,70
65% | 2,52
1,69
49% | 5,47
10,9
-50% | 7,56
7,49
0,90% |
5,06
|
5,05
|
5,43
|
5,93
|
5,55
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | -19,6
-17,8
-10% | -16,7
-13,9
-20% | -16,7
-18,0
7,2% | -20,4
-16,3
-25% | -24,1
-22,5
-7,0% | -27,1
-25,6
-6,1% | -29,1
-28,3
-2,6% | -34,5
-30,1
-15% | -28,7
-22,3
-29% | -31,5
-28,3
-11% |
-35,0
|
-37,3
|
-37,8
|
-40,2
|
-42,2
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | -19,7
-17,4
-13% | -16,8
-13,9
-21% | -16,0
-18,2
12% | -19,8
-15,8
-25% | -23,5
-21,7
-8,3% | -26,6
-25,3
-5,0% | -28,3
-27,9
-1,3% | -33,5
-29,7
-13% | -28,1
-21,1
-33% | -58,7
-27,2
-116% |
-33,1
|
-36,3
|
-36,8
|
-39,1
|
-41,2
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | -19,7
-18,0
-9,4% | -16,8
-16,2
-3,4% | -16,0
-18,0
11% | -19,8
-16,2
-22% | -23,5
-21,7
-8,1% | -26,6
-25,5
-4,5% | -28,3
-28,2
-0,23% | -33,5
-29,3
-15% | -28,1
-21,6
-30% | -58,7
-27,2
-116% |
-33,5
|
-36,3
|
-36,8
|
-39,1
|
-41,2
|
Net income
$ |
Released
Forecast
Spread | -0,37
-0,31
-19% | -0,31
-0,25
-25% | -0,25
-0,25
0,79% | -0,30
-0,23
-29% | -0,36
-0,33
-10% | -0,40
-0,38
-5,3% | -0,37
-0,39
4,9% | -0,44
-0,39
-13% | -0,35
-0,29
-22% | -0,68
-0,32
-110% |
-0,39
|
-0,41
|
-0,42
|
-0,45
|
-0,46
| | Announcement Date | 08/06/2018 | 11/01/2018 | 03/05/2019 | 05/07/2019 | 08/06/2019 | 11/05/2019 | 03/02/2020 | 05/11/2020 | 08/05/2020 | 11/05/2020 | | | | | |
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
Previous period
